Colonoscopy? No thank you!

The diagnosis and severity grading of intestinal conditions such as Crohn’s disease typically require a complete colonoscopy with biopsy and relative histopathology exam. The VIGOR++ system makes possible to replace these invasive, unpleasant, and expensive exams with a simple magnetic resonance imaging session, followed by a patient-specific computer simulation.

The VIGOR++ software is now available for clinical research use via the 3Dnet™ medical imaging cloud service (www.3dnetmedical.com). Full-scale clinical trials are being designed at the Academic Medical Center, Amsterdam, and the UCL Hospital, London.

Tielbeek JA, Löwenberg M, Bipat S, Horsthuis K, Ponsioen CY, D'Haens GR, Stoker J. Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease. Inflamm Bowel Dis. 2013 Aug;19(9):1943-50. 10.1097/MIB.0b013e3182905536
Tielbeek, JA; Makanyanga, JC; Bipat, S; Pendsé, DA; Nio, CY; Vos, FM; Taylor, SA; Stoker, J; - (2013) Grading Crohn Disease Activity With MRI: Interobserver Variability of MRI Features, MRI Scoring of Severity, and Correlation With Crohn Disease Endoscopic Index of Severity. AJR Am J Roentgenol, 201 (6) 1220 - 1228. DOI:10.2214/AJR.12.10341
Mahapatra D, Schueffler P, Tielbeek J, Makanyanga J, Stoker J, Taylor S, VosF, Buhmann J., Automatic Detection and Segmentation of Crohn's Disease Tissues from Abdominal MRI, IEEE Trans Med Imaging. 2013.
Public dissemination: Euronews documentary www.euronews.com/2013/07/01/crohn-s-disease-the-inside-story 

Avicenna Alliance news

Avicenna present at the European Research & Innovation Days

The European Research and Innovation days was a three-day event in Brussels, during which researchers, academics, businesses,...

find out more ›

SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019

Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the...

find out more ›

Avicenna answers online consultation to shape Horizon Europe

On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework...

find out more ›

Prestigious FDA award allocated to group that developed the V&V 40 standard

The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up